Clinical Trials in New York State

Showing 2201-2220 of 17,167 trials

Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3

NCT06595030

Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients. For this single-arm, randomized, placebo-controlled study, the researchers plan to recruit 100 participants who will experience either the active TLI or the placebo for 6 months.

Alzheimer's DiseaseMild Cognitive Impairment

Icahn School of Medicine at Mount Sinai101 participantsStarted Dec 2024

Menands, New York, United States • New York, New York, United States

TERMINATED86 miles

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

NCT06026332

Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting

Bladder Cancer

Ferring Pharmaceuticals202 participantsStarted Sep 2023

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +28 more locations

Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Find Trials by Condition in New York State

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

Conditioning SCID Infants Diagnosed Early

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)